Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch ...
A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it ...
Detailed price information for Tandem Diabetes Care (TNDM-Q) from The Globe and Mail including charting and trades.
Medpage Today on MSN
World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA
An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...
What is this about: On August 7, 2025, before the market opened, the company issued a press release entitled "Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 ...
In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...
Pregnant women with type 1 diabetes who use a closed-loop insulin delivery system spend more hours daily in the ...
Travel Noire on MSN
Wheels Up, Insulin Packed: How To Travel Boldly With Diabetes
Since her 2021 diabetes diagnosis, Stephanie Guignard, a nurse practitioner, has made it her mission to educate people on how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback